{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T06:28:42Z","timestamp":1790749722731,"version":"4.1.0"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["RS-2024-00440371"],"award-info":[{"award-number":["RS-2024-00440371"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002456","name":"Chonnam National University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002456","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Neuropsychopharmacology"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.euroneuro.2025.03.004","type":"journal-article","created":{"date-parts":[[2025,4,14]],"date-time":"2025-04-14T08:37:53Z","timestamp":1744619873000},"page":"33-39","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Exploring the prospective association of serum interleukin-1\u03b2 and brain-derived neurotrophic factor with antidepressant treatment response"],"prefix":"10.1016","volume":"95","author":[{"given":"Chan-Yeong","family":"Cho","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji Hyeon","family":"Jeon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hee-Ju","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ju-Wan","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Jhon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ju-Yeon","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung-Wan","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Il-Seon","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae-Min","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.euroneuro.2025.03.004_bib0001","series-title":"Diagnostic and Statistical Manual of Mental Disorders","year":"1994"},{"key":"10.1016\/j.euroneuro.2025.03.004_bib0002","series-title":"Diagnostic and Statistical Manual of Mental disorders: DSM-IV-TR","year":"2000"},{"key":"10.1016\/j.euroneuro.2025.03.004_bib0003","doi-asserted-by":"crossref","first-page":"68","DOI":"10.3389\/fncel.2013.00068","article-title":"Interplay between pro-inflammatory cytokines and growth factors in depressive illnesses","volume":"7","author":"Audet","year":"2013","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.euroneuro.2025.03.004_bib0004","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.euroneuro.2020.11.009","article-title":"Higher baseline interleukin-1\u03b2 and TNF-\u03b1 hamper antidepressant response in major depressive disorder","volume":"42","author":"Benedetti","year":"2021","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.euroneuro.2025.03.004_bib0005","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.neuropharm.2015.10.034","article-title":"BDNF - a key transducer of antidepressant effects","volume":"102","author":"Bj\u00f6rkholm","year":"2016","journal-title":"Neuropharmacology"},{"issue":"4","key":"10.1016\/j.euroneuro.2025.03.004_bib0006","doi-asserted-by":"crossref","first-page":"423","DOI":"10.15288\/jsa.1995.56.423","article-title":"The alcohol use disorders identification test (AUDIT): validation of a screening instrument for use in medical settings","volume":"56","author":"Bohn","year":"1995","journal-title":"J. Stud. Alcohol"},{"key":"10.1016\/j.euroneuro.2025.03.004_bib0007","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.pnpbp.2018.06.003","article-title":"Plasma biomarkers in a placebo-controlled trial comparing tDCS and escitalopram efficacy in major depression","volume":"86","author":"Brunoni","year":"2018","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2025.03.004_bib0008","doi-asserted-by":"crossref","first-page":"430","DOI":"10.3389\/fncel.2014.00430","article-title":"Brain-derived neurotrophic factor: a bridge between inflammation and neuroplasticity","volume":"8","author":"Calabrese","year":"2014","journal-title":"Front. Cell. Neurosci."},{"issue":"5","key":"10.1016\/j.euroneuro.2025.03.004_bib0009","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1016\/j.cell.2021.01.034","article-title":"Antidepressant drugs act by directly binding to TRKB neurotrophin receptors","volume":"184","author":"Casarotto","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.euroneuro.2025.03.004_bib0010","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2023.1188672","article-title":"Brain-derived neurotrophic factor (BDNF) has direct anti-inflammatory effects on microglia","volume":"17","author":"Charlton","year":"2023","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.euroneuro.2025.03.004_bib0011","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.bbi.2021.01.029","article-title":"Interactive effects of systemic inflammation and life stressors on treatment response of depressive disorders","volume":"95","author":"Choi","year":"2021","journal-title":"Brain Behav. Immun."},{"issue":"12","key":"10.1016\/j.euroneuro.2025.03.004_bib0012","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.5498\/wjp.v14.i12.1804","article-title":"Interaction between serum inflammatory cytokines and brain-derived neurotrophic factor in cognitive function among first-episode schizophrenia patients","volume":"14","author":"Cui","year":"2024","journal-title":"World J. Psychiatry"},{"issue":"1","key":"10.1016\/j.euroneuro.2025.03.004_bib0013","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/imr.12621","article-title":"Overview of the IL-1 family in innate inflammation and acquired immunity","volume":"281","author":"Dinarello","year":"2018","journal-title":"Immunol. Rev."},{"issue":"3","key":"10.1016\/j.euroneuro.2025.03.004_bib0014","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.jad.2012.08.007","article-title":"Might different cytokine trends in depressed patients receiving duloxetine indicate differential biological backgrounds","volume":"145","author":"Fornaro","year":"2013","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.euroneuro.2025.03.004_bib0015","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.jad.2017.07.001","article-title":"Peripheral biomarkers of major depression and antidepressant treatment response: current knowledge and future outlooks","volume":"233","author":"Gadad","year":"2018","journal-title":"J. Affect. Disord."},{"issue":"12","key":"10.1016\/j.euroneuro.2025.03.004_bib0016","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1002\/jcph.963","article-title":"Effect of agomelatine and fluoxetine on HAM-D score, serum brain-derived neurotrophic factor, and tumor necrosis factor-\u03b1 level in patients with major depressive disorder with severe depression","volume":"57","author":"Gupta","year":"2017","journal-title":"J. Clin. Pharmacol."},{"issue":"1","key":"10.1016\/j.euroneuro.2025.03.004_bib0017","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1136\/jnnp.23.1.56","article-title":"A rating scale for depression","volume":"23","author":"Hamilton","year":"1960","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"5","key":"10.1016\/j.euroneuro.2025.03.004_bib0018","doi-asserted-by":"crossref","first-page":"538","DOI":"10.30773\/pi.2017.10.2","article-title":"The MAKE biomarker discovery for enhancing antidepressant treatment effect and response (MAKE BETTER) study: design and methodology","volume":"15","author":"Kang","year":"2018","journal-title":"Psychiatry Investig."},{"key":"10.1016\/j.euroneuro.2025.03.004_bib0019","doi-asserted-by":"crossref","DOI":"10.1016\/j.psychres.2023.115198","article-title":"Age-specific associations between inflammatory markers and remission of depression during antidepressant use","volume":"324","author":"Kim","year":"2023","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.euroneuro.2025.03.004_bib0020","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.bbi.2022.05.012","article-title":"Prospective associations of multimodal serum biomarkers with 12-week and 12-month remission in patients with depressive disorders receiving stepwise psychopharmacotherapy","volume":"104","author":"Kim","year":"2022","journal-title":"Brain Behav. Immun."},{"issue":"3","key":"10.1016\/j.euroneuro.2025.03.004_bib0021","doi-asserted-by":"crossref","first-page":"490","DOI":"10.9758\/cpn.2021.19.3.490","article-title":"Predictors of remission in acute and continuation treatment of depressive disorders","volume":"19","author":"Kim","year":"2021","journal-title":"Clin. Psychopharmacol. Neurosci."},{"key":"10.1016\/j.euroneuro.2025.03.004_bib0022","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.jad.2020.05.002","article-title":"Short and long-term treatment outcomes of stepwise psychopharmacotherapy based on early clinical decision in patients with depressive disorders","volume":"274","author":"Kim","year":"2020","journal-title":"J. Affect. Disord."},{"issue":"9","key":"10.1016\/j.euroneuro.2025.03.004_bib0023","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1177\/0269881117711708","article-title":"Anti-inflammatory treatment for major depressive disorder: implications for patients with an elevated immune profile and non-responders to standard antidepressant therapy","volume":"31","author":"Kopschina Feltes","year":"2017","journal-title":"J. Psychopharmacol."},{"issue":"3","key":"10.1016\/j.euroneuro.2025.03.004_bib0024","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.pnpbp.2010.08.026","article-title":"In animal models, psychosocial stress-induced (neuro)inflammation, apoptosis and reduced neurogenesis are associated to the onset of depression","volume":"35","author":"Kubera","year":"2011","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"issue":"7","key":"10.1016\/j.euroneuro.2025.03.004_bib0025","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1113\/EP090780","article-title":"Beyond an inflammatory mediator: interleukin-1 in neurophysiology","volume":"108","author":"Lima","year":"2023","journal-title":"Exp. Physiol."},{"issue":"1","key":"10.1016\/j.euroneuro.2025.03.004_bib0026","doi-asserted-by":"crossref","first-page":"12346","DOI":"10.1038\/s41598-024-62381-9","article-title":"Temporal and spatial trend analysis of all-cause depression burden based on Global Burden of Disease (GBD) 2019 study","volume":"14","author":"Liu","year":"2024","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.euroneuro.2025.03.004_bib0027","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1038\/s41380-019-0474-5","article-title":"Peripheral cytokine levels and response to antidepressant treatment in depression: a systematic review and meta-analysis","volume":"25","author":"Liu","year":"2020","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2025.03.004_bib0028","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.euroneuro.2024.06.008","article-title":"The effect of antidepressant treatment on blood BDNF levels in depressed patients: a review and methodological recommendations for assessment of BDNF in blood","volume":"87","author":"Madsen","year":"2024","journal-title":"Eur. Neuropsychopharmacol."},{"issue":"5","key":"10.1016\/j.euroneuro.2025.03.004_bib0029","doi-asserted-by":"crossref","first-page":"pyw003","DOI":"10.1093\/ijnp\/pyw003","article-title":"Agomelatine increases BDNF serum levels in depressed patients in correlation with the improvement of depressive symptoms","volume":"19","author":"Martinotti","year":"2016","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"15","key":"10.1016\/j.euroneuro.2025.03.004_bib0030","doi-asserted-by":"crossref","first-page":"2955","DOI":"10.1007\/s00213-014-3475-8","article-title":"High baseline BDNF serum levels and early psychopathological improvement are predictive of treatment outcome in major depression","volume":"231","author":"Mikoteit","year":"2014","journal-title":"Psychopharmacology (Berl)"},{"issue":"9","key":"10.1016\/j.euroneuro.2025.03.004_bib0031","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/j.biopsych.2008.11.029","article-title":"Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression","volume":"65","author":"Miller","year":"2009","journal-title":"Biol. Psychiatry"},{"issue":"1","key":"10.1016\/j.euroneuro.2025.03.004_bib0032","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/nri.2015.5","article-title":"The role of inflammation in depression: from evolutionary imperative to modern treatment target","volume":"16","author":"Miller","year":"2016","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.euroneuro.2025.03.004_bib0033","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/7260130","article-title":"Brain-derived neurotrophic factor, depression, and physical activity: making the neuroplastic connection","author":"Phillips","year":"2017","journal-title":"Neural. Plast."},{"key":"10.1016\/j.euroneuro.2025.03.004_bib0034","doi-asserted-by":"crossref","first-page":"17989","DOI":"10.1038\/srep17989","article-title":"A method for reproducible measurements of serum BDNF: comparison of the performance of six commercial assays","volume":"5","author":"Polacchini","year":"2015","journal-title":"Sci. Rep."},{"issue":"8","key":"10.1016\/j.euroneuro.2025.03.004_bib0035","doi-asserted-by":"crossref","first-page":"e611","DOI":"10.1038\/tp.2015.104","article-title":"IL-1\u03b2 and BDNF are associated with improvement in hypersomnia but not insomnia following exercise in major depressive disorder","volume":"5","author":"Rethorst","year":"2015","journal-title":"Transl. Psychiatry"},{"issue":"3","key":"10.1016\/j.euroneuro.2025.03.004_bib0036","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1017\/S0033291721004943","article-title":"Clinical research challenges posed by difficult-to-treat depression","volume":"52","author":"Rush","year":"2022","journal-title":"Psychol. Med."},{"key":"10.1016\/j.euroneuro.2025.03.004_bib0037","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.euroneuro.2020.09.633","article-title":"Value of peripheral neurotrophin levels for the diagnosis of depression and response to treatment: a systematic review and meta-analysis","volume":"41","author":"Shi","year":"2020","journal-title":"Eur. Neuropsychopharmacol."},{"issue":"3","key":"10.1016\/j.euroneuro.2025.03.004_bib0038","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1590\/1806-9282.65.3.361","article-title":"Increased levels of plasma IL-1b and BDNF can predict resistant depression patients","volume":"65","author":"Uint","year":"2019","journal-title":"Rev. Assoc. Med. Bras. (1992)"},{"issue":"6","key":"10.1016\/j.euroneuro.2025.03.004_bib0039","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1111\/j.1600-0447.1983.tb09716.x","article-title":"The hospital anxiety and depression scale","volume":"67","author":"Zigmond","year":"1983","journal-title":"Acta Psychiatr. Scand."},{"issue":"4","key":"10.1016\/j.euroneuro.2025.03.004_bib0040","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1038\/npp.2011.277","article-title":"Interleukin-1beta: a new regulator of the kynurenine pathway affecting human hippocampal neurogenesis","volume":"37","author":"Zunszain","year":"2012","journal-title":"Neuropsychopharmacology"}],"container-title":["European Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X25000598?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X25000598?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T05:41:44Z","timestamp":1762321304000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924977X25000598"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":40,"alternative-id":["S0924977X25000598"],"URL":"https:\/\/doi.org\/10.1016\/j.euroneuro.2025.03.004","relation":{},"ISSN":["0924-977X"],"issn-type":[{"value":"0924-977X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Exploring the prospective association of serum interleukin-1\u03b2 and brain-derived neurotrophic factor with antidepressant treatment response","name":"articletitle","label":"Article Title"},{"value":"European Neuropsychopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euroneuro.2025.03.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. and ECNP. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}